Abstract
This chapter covers the preparation of a purified nuclear magnetic resonance (NMR) peptide sample for analysis considering purity, pI, oxidation status, and solubility of the sample, along with the choice and preparation of the NMR sample tube. The NMR analysis of therapeutic peptides is an area that is still underdeveloped, but it offers both great promise and utility in drug screening and design (1–3). Ligand-target NMR-screening methods, such as saturation transfer difference NMR (STD-NMR;4) rely on correct NMR assignments of potential ligands to relate binding proximity to ligand-target structural arrangement. Furthermore, both nascent and stabilized therapeutic peptide structures from aqueous-based media can be related to binding efficacy and can enhance the design of future therapeutics via in silico analysis of data that is, in turn, reliant on correct NMR assignment. Accurate assignment and structural analysis of such peptides is ultimately obtained from high-quality NMR data that is achieved from meticulous sample preparation. It is feasible to run the necessary NMR experiments for the structural elucidation of a single high-quality 20-mer peptide sample in 12–18 h and to assign and obtain a structure from the data in 1–5 d. This is in contrast to the processes required for determining protein structures (5). The structural study of therapeutic peptides is long overdue as a routine analytical step and holds potential for the future. It is anticipated that the procedures described here will encourage research groups and scientists to prepare their peptides of interest for such structural work and present them to the high-resolution NMR facility in their organization for data acquisition and analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Roberts, G. C. K. (2000) Applications of NMR in drug discovery. Drug Discov. Today 5, 230–240.
Shapiro, M. (2001) Applications of NMR screening in the pharmaceutical industry. Il Farmaco 56, 141–143.
Pellecchia, M., Sem, D. S., and Wüthrich, K. (2002) NMR in drug discovery. Nature Rev. Drug Discov. 1, 211–219.
Mayer, M. and Meyer, B. (2001) Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein. J. Am. Chem. Soc. 123, 6108–6117.
Howard, M. J. (1998) Protein NMR spectroscopy. Current Biol. 8, R331–R333.
Dawson, R. M. C., Elliott, D. C., Elliott, W. H., and Jones, K. M. pH, buffers and physiological media, in Data for Biochemical Research, 3rd ed. Oxford University Press, 2002, pp. 417–448.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Howard, M.J. (2005). Sample Preparation Procedures for High-Resolution Nuclear Magnetic Resonance Studies of Aqueous and Stabilized Solutions of Therapeutic Peptides. In: Smales, C.M., James, D.C. (eds) Therapeutic Proteins. Methods in Molecular Biology™, vol 308. Humana Press. https://doi.org/10.1385/1-59259-922-2:461
Download citation
DOI: https://doi.org/10.1385/1-59259-922-2:461
Publisher Name: Humana Press
Print ISBN: 978-1-58829-390-9
Online ISBN: 978-1-59259-922-6
eBook Packages: Springer Protocols